Somatuline Depot Solution For Injection 120Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Somatuline Depot: Solution for injection (120mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

LANREOTIDE (lan REE oh tide) is used to reduce blood levels of growth hormone in patients with a condition called acromegaly. It also works to slow or stop tumor growth in patients with gastroenteropancreatic neuroendocrine tumor (GEP-NET).

In-Depth Information
Select a Medication

Somatuline Depot 120mg/0.5ml Solution for Injection

NDC: 150540120
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Carcinoid, Neuroendocrine Tumor (NET), Acromegaly

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Store in original container
Somatuline Depot 120mg/0.5ml Solution for Injection

Reported Side Effects for Somatuline Depot 120mg/0.5ml Solution for Injection

Muscle And/Or Bone Pain Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Lightheadedness Incidence:
<9.0%*
Severity: MILD
Onset: EARLY
Antibody Formation Incidence:
<10.5%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stomach Pain Incidence:
<6.0%*
Severity: SEVERE
Onset: EARLY
Underactive Thyroid Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Gallstones Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Depression Incidence:
<7.0%*
Severity: MODERATE
Onset: DELAYED
Shortness Of Breath Incidence:
<6.0%*
Severity: MODERATE
Onset: EARLY
High Blood Pressure Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Diabetes Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Slow Heart Beat Incidence:
1.0-23.0%*
Severity: SEVERE
Onset: RAPID
Anemia Incidence:
3.0-7.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
7.0-14.0%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
7.0-16.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Low Blood Sugar Incidence:
7.0%*
Severity: MODERATE
Onset: EARLY
Constipation Incidence:
8.0%*
Severity: MODERATE
Onset: DELAYED
Weight Loss Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Injection Site Reaction Incidence:
9.0-15.0%*
Severity: MILD
Onset: RAPID
Upset Stomach Incidence:
11.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
26.0-65.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Somatuline Depot 120mg/0.5ml Solution for Injection

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Marijuana and Somatuline Depot 120mg/0.5ml Solution for Injection(Lanreotide)
Marijuana and Lanreotide(Lanreotide)
Lanreotide can theoretically decrease the elimination of Marijuana, Medical from the body. Side effects from Marijuana, Medical may worsen if you take Lanreotide. You may feel drowsy or more tired. Do not drive or operate machinery until you know how these drugs affect you. Contact your health care provider immediately if you notice slurred speech, confusion, increases heart rate, or palpitations while taking Marijuana, Medical.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Somatuline Depot

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5